Managing the science in the presence of financial conflict of interest

Samsa, Greg; Solomon, Alexandra

doi:10.1080/08989621.2019.1636652

Cited by 3 publications

(2 citation statements)

References 3 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The policies of COI usually focus on financial benefits. These policies concern management and prevention of COI rather than punishment, as they do not assume that financial benefits or any secondary interest could influence the professional’s judgment ( Cherla et al ., 2019 ; Samsa and Solomon, 2019 ). However, evidence exists showing that COIs influence professional judgment ( Elliott, 2008 ).…”

Section: Introductionmentioning

confidence: 99%

“…The system is an open database that contains information on payments to academic researchers made by the industry ( Chabner and Bates, 2018 ). Additionally, scientific reviewers who can assess the rigor and transparency of the research in fair and efficient ways are another layer to ensuring proper management of COI ( Samsa and Solomon, 2019 ).…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Awareness and perception of pharmacy researchers about conflict of interest: A study from the MENA region

Mashaqhbeh¹,

Alzoubi²,

Khabour³

et al. 2022

j app pharm sci

View full text Add to dashboard Cite

The literature has shown some bias in research about the effectiveness and efficacy of medications due to the influence of the pharmaceutical industry. Thus, researchers' understanding of conflict of interest (COI) is substantial and may influence the quality of scientific research. Therefore, in this study, we aimed to assess pharmacy researchers' awareness and perception about COI in the Middle East and North Africa (MENA) region and the factors affecting their disclosure of COI. In this cross-sectional study, a convenience sample of pharmacy researchers from the MENA region was surveyed for their awareness and perception about the principles of COI. The questionnaire was divided into three main sections. The first section assesses the demographic information of the study participants; the second section assesses researchers' awareness and practices in dealing with COI; and, finally, the third section assesses participants' perception about COI. The questionnaire was uploaded on the Google Forms electronic platform, and it was distributed to the potential study participants via their professional emails. Finally, logistic analysis was used to evaluate predictors affecting COI disclosure by the study participants. A total of 271 pharmacy researchers participated in this study. Researchers were distributed based on their academic rank as follows: 63 professors (23.3%), 59 associate professors (21.8%), 97 assistant professors (35.8%), and 52 lecturers (19.2%). The majority of researchers indicated that they were familiar with the concept of COI (88.9%), and they agreed that the existence of COI should be disclosed by all authors (84.5%). About 33.2% of the study participants did not know if their institution had a policy for COI. About half of the participants (48.70%) believed that disclosure is the only way for the management of COI. However, only 41.7% of them (n = 113) indicated that they had disclosed COI in their published research. Finally, participants who have a collaboration with the industry showed a significantly lower tendency to disclose their COI than those who do not have any partnership with the industry (OR = 0.471, p = 0.017). The majority of the pharmacy researchers from the MENA region are familiar with the principles of COI, but a lower percentage of them disclose their COI in their published research. Efforts should be made to educate researchers about the importance of disclosing COI, which might reduce the potential of bias in their published research.

show abstract

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Awareness and perception of pharmacy researchers about conflict of interest: A study from the MENA region

Mashaqhbeh¹,

Alzoubi²,

Khabour³

et al. 2022

j app pharm sci

View full text Add to dashboard Cite

show abstract

Institutional approaches to preventing questionable research practices

Troy

Rockhold

Samsa

2021

Accountability in Research

View full text Add to dashboard Cite

An Analysis of Industry Payments Toward Physicians in the United States—Cryolipolysis

Jaszkul,

Kemp,

Alghanim

et al. 2023

Plast Surg (Oakv)

View full text Add to dashboard Cite

Background : Cryolipolysis has emerged as a nonsurgical fat reduction alternative to liposuction. Industry payments may impact how physician authors view medical devices in the literature. Under-reporting financial conflicts of interest has raised concerns about full transparency between industry and physicians. Objectives : We aim to determine the impact industry payments to physicians have on the cryolipolysis literature and whether there is under-reporting of financial conflicts of interest in the literature. Methods : We collated all articles that cite the pivotal trial in the Food and Drug Administration approval of a cryolipolysis device. Articles were read independently and coded as favourable or neutral. A separate researcher screened the Centers for Medicare & Medicaid Services Open Payments database for direct or in-kind payments and recorded financial conflicts of interest. Results : A total of 19 articles met the inclusion criteria. This included 37 unique authors across multiple specialties. Eighteen (95%) published articles had at least one author who received industry payment. Payments totalled $1,476,564.16. Twelve (63%) articles were positive, and 7 (37%) neutral. Of the 31 authors who received payments, 11 (35%) did not report a conflict of interest. The majority of industry payments assessed were for consulting fees, which totalled $980,334.86 (66.4%). Conclusions : We found the majority of published opinions on cryolipolysis from the United States were written by physicians who received industry payments. We also found financial conflicts of interest around cryolipolysis devices are under-reported in the literature.

show abstract

Managing the science in the presence of financial conflict of interest

Cited by 3 publications

References 3 publications

Awareness and perception of pharmacy researchers about conflict of interest: A study from the MENA region

Awareness and perception of pharmacy researchers about conflict of interest: A study from the MENA region

Institutional approaches to preventing questionable research practices

An Analysis of Industry Payments Toward Physicians in the United States—Cryolipolysis

Contact Info

Product

Resources

About